Conflict of Interest Disclosures for Society Leadership

President
Robert Negrin, MD, Stanford University
Consultancy and Equity Ownership (multiple companies), Membership on a Board or Advisory Committee DSMB for a clinical study of CAR T cells.

President-Elect
Cynthia E. Dunbar, MD, National Institutes of Health
Research funding from Be Bio, Disc Medicine, and Novartis; Honoraria from UpToDate.

Vice President
Alison Loren, MD, MSCE, University of Pennsylvania
NCCN Guidelines Membership on a Board or Advisory Committee, Vice Chair, Hematopoietic Cell Transplant Guideline Panel.

Secretary
Jennifer Brown, MD, PhD, Dana-Farber Cancer Institute
Funding for an investigator initiated trial with correlatives, Membership on a Board or Advisory Committe, and Member of the iwCLL and Chair of the 2023 iwCLL meeting in Boston.

Treasurer
Joseph R. Mikhael, MD, FRCPC, MEd, Translational Genomics Research Institute
Honoraria from Amgen, GSK, Janssen, Karyopharm, Sanofi, and Takeda; and Consultancy for BMS and Pfizer.

Blood Editor-in-Chief
Andrew Roberts, MBBS, PhD, Walter & Eliza Hall Institute
Membership on a Board or Advisory Committee, Member of the Board of Directors with stock options, SAB member, and Neogene Honoraria.

Executive Director
Martha Liggett, American Society of Hematology
Indicated no conflicts of interest.

Deputy Executive Director
Matthew Gertzog, American Society of Hematology
Equity ownership of Amgen.